Regeneron Shares Advance on Sanofi’s Plan to Buy Stock

Regeneron Pharmaceuticals Inc., maker of the eye medicine Eylea, rose the most in three weeks on drug-development partner Sanofi’s plans to raise its stake in the company by buying shares on the stock market.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.